
Alpa Laboratories Q2 Results FY27: Net Loss Rs 1.85 Cr, Revenue Up 17.97% to Rs 30.98 Cr
Updated: 14 Nov 2026 • 8:55 pm
Posted by:

Quick Answer
Alpa Laboratories Q2 Results FY27 were declared on 14 November 2026 on a Consolidated basis. The quarterly results show revenue of Rs 30.98 Cr, up 17.97% from Rs 26.26 Cr a year earlier, which is YoY growth of 17.97%. The net loss was Rs 1.85 Cr against a profit of Rs 0.11 Cr, while Operating Profit stayed negative at a loss of Rs 2.22 Cr.
Alpa Laboratories Ltd (ALPA) Q2 Results FY27 announced on 14 November 2026, covering the company's financial performance for the July to September 2026 quarter. Alpa Laboratories Q2 Results FY27 show revenue of Rs 30.98 Cr and a PAT loss of Rs 1.85 Cr on a Consolidated basis. The results date anchors every comparison in this article, and the consolidated results are measured against the same quarter last year.
This Alpa Laboratories Q2 Results results analysis covers the financial highlights, business drivers, outlook and risks behind the numbers. It starts with the Financial Highlights table, which sets revenue, Operating Profit and PAT for the quarter beside the same quarter last year.
Click Here – Get Free Investment Predictions
Alpa Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 30.98 Cr | Rs 26.26 Cr | +17.97% YoY |
| Operating Profit | Rs -2.22 Cr | Rs -2.24 Cr | +0.89% YoY |
| Net Profit (PAT) | Rs -1.85 Cr | Rs 0.11 Cr | -1781.82% YoY |
Source: company filing for Alpa Laboratories Q2 Results FY27, 14 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Alpa Laboratories Q2 Results: What Stands Out
- Revenue: Revenue stood at Rs 30.98 Cr, up 17.97% from Rs 26.26 Cr a year earlier, a healthy YoY growth figure for the business.
- Net loss: The net loss was Rs 1.85 Cr against a profit of Rs 0.11 Cr a year earlier, so PAT moved from positive to negative over the same comparison.
- Operating Profit: Operating Profit was a loss of Rs 2.22 Cr against a loss of Rs 2.24 Cr, almost unchanged from the same quarter last year.
- Margin: Net profit margin narrowed to -6.0% from 0.4% in the comparison quarter, so profit moved lower while sales rose.
- Next step: The Alpa Laboratories Q2 Results FY27: Performance Analysis below explains how these movements fit together.
Alpa Laboratories Q2 Results FY27: Performance Analysis
Alpa Laboratories Q2 Results FY27 show a quarter in which revenue rose while the profit lines stayed weak against the same quarter last year. Revenue reached Rs 30.98 Cr, Operating Profit was a loss of Rs 2.22 Cr and the net loss was Rs 1.85 Cr on a Consolidated basis. The sharpest movement came in net profit, which went from Rs 0.11 Cr to a loss, with revenue up 17.97%.
Revenue added Rs 4.72 Cr over the same quarter last year, while the Operating Profit loss stayed near Rs 2.2 Cr and PAT moved by Rs 1.96 Cr from profit to loss. This gap between sales and profit in the YoY growth figures is the pattern the Alpa Laboratories Q2 Results margin numbers reflect later in this article.
Investors tracking Alpa Laboratories Q2 Results FY27 can watch later disclosures to see how these numbers carry forward. The Univest Screener helps readers set these quarterly results beside other companies that have declared, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis points first to revenue, which grew 18.0% year on year to Rs 30.98 Cr in the latest quarter and forms the top line behind every profit figure in Alpa Laboratories Q2 Results FY27.
Low Debt – The company is almost debt free, with a debt-to-assets ratio of 0.01 in FY26, a full-year balance sheet point that sits beside the quarterly figures in Alpa Laboratories Q2 Results FY27.
FY27 Outlook After Alpa Laboratories Q2 Results
The full-year FY27 outcome will depend on the quarters reported after the results date and on the conditions the company discloses along the way. This results analysis therefore reads the latest quarter as one data point rather than a projection for later periods.
Alpa Laboratories Q2 Results FY27 give a net loss of Rs 1.85 Cr as the latest reference point, with return on equity of 8.38% in FY26 as the earlier full-year benchmark. The Univest app can help readers follow the next filing, while the risks below show what to keep in view.
Key Risks to Watch After Alpa Laboratories Q2 Results FY27
Net Loss
The company reported a net loss of Rs 1.85 Cr in the latest quarter, against a profit of Rs 0.11 Cr a year earlier, which makes the loss line the first item to track after Alpa Laboratories Q2 Results FY27.
Narrower Net Profit Margin
Net profit margin narrowed to -6.0% from 0.4% in the comparison quarter. That quarterly ratio shows profit moving lower while revenue rose in Alpa Laboratories Q2 Results FY27.
Low Return on Equity
Return on equity was low at 8.38% in FY26. That full-year ratio sits alongside the quarterly figures in Alpa Laboratories Q2 Results FY27 and is worth reading with every later filing.
Modest Return on Capital Employed
Return on capital employed was modest at 9.39% in FY26. That full-year ratio sits beside the quarterly results and is worth reading with every later filing.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Alpa Laboratories Q2 Results FY27 record revenue of Rs 30.98 Cr and a net loss of Rs 1.85 Cr, with revenue higher and PAT weaker than a year earlier. These quarterly results come with loss and margin points that the risks section sets out. Taken together, the Alpa Laboratories Q2 Results consolidated results give investors a factual base, and they should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Alpa Laboratories Q2 Results FY27
What are Alpa Laboratories Q2 Results FY27?
Ans. Alpa Laboratories Q2 Results FY27 are the quarterly results for July to September 2026, declared on a Consolidated basis. They cover revenue, Operating Profit and net profit, as laid out in the Financial Highlights section.
What is the results date for Alpa Laboratories Q2 Results FY27?
Ans. The results date for Alpa Laboratories was 14 November 2026, when the Consolidated numbers were declared. Alongside this, the opening section explains how that date frames the comparison with the same quarter last year.
What revenue was reported in Alpa Laboratories Q2 Results FY27?
Ans. Alpa Laboratories reported revenue of Rs 30.98 Cr, compared with Rs 26.26 Cr a year earlier. Alongside this, that gap equals YoY growth of 17.97%, as the Performance Analysis section shows.
What net profit was reported in Alpa Laboratories Q2 Results FY27?
Ans. Alpa Laboratories reported a net loss of Rs 1.85 Cr on the results date, against a profit of Rs 0.11 Cr a year earlier. This means PAT moved lower, a point the Key Takeaways section sets out.
How much YoY growth did revenue show in Alpa Laboratories Q2 Results FY27?
Ans. Revenue showed YoY growth of 17.97%, rising from Rs 26.26 Cr to Rs 30.98 Cr. Compared with this, PAT moved from a profit to a loss, which the Performance Analysis section explains.
Did net profit rise or fall in Alpa Laboratories Q2 Results?
Ans. Net profit fell into a loss for Alpa Laboratories, at Rs 1.85 Cr against a profit of Rs 0.11 Cr a year earlier. So the net profit margin narrowed to -6.0% from 0.4%, as the Key Risks section notes.
What was the Operating Profit in Alpa Laboratories Q2 Results FY27?
Ans. Operating Profit was a loss of Rs 2.22 Cr, against a loss of Rs 2.24 Cr a year earlier. This means it stayed almost flat while revenue rose, as the Performance Analysis section shows.
Are Alpa Laboratories Q2 Results consolidated results or standalone results?
Ans. Alpa Laboratories Q2 Results are consolidated results, since the figures follow the Consolidated basis as declared. So the revenue and profit values in the Financial Highlights table are consolidated figures, not standalone ones.
What business factors shaped Alpa Laboratories Q2 Results FY27?
Ans. Alpa Laboratories Q2 Results FY27 point to revenue growth of 18.0% and a debt-to-assets ratio of 0.01 in FY26, which means the company is almost debt free. These appear in the Key Business Factors section.
What are the key risks after Alpa Laboratories Q2 Results FY27?
Ans. The key risks are a net loss of Rs 1.85 Cr and a narrower margin of -6.0% in the latest quarter. Alongside these, return on equity was low at 8.38%, as the Key Risks section explains.
What is the outlook after Alpa Laboratories Q2 Results?
Ans. Alpa Laboratories Q2 Results leave the full-year FY27 outlook dependent on quarters still to be reported. So the Outlook section treats this quarter as one reference point, with a net loss of Rs 1.85 Cr.
Where can I find the complete Alpa Laboratories Q2 Results FY27 data?
Ans. Alpa Laboratories Q2 Results FY27 data is gathered in the Financial Highlights table and nearby sections. Readers can also compare these quarterly results with other companies using the Univest Screener, where the results analysis continues.
Recent Articles

AB Cotspin India Q2 Results FY27: PAT Jumps 56.35% to Rs 5.66 Cr, Revenue Rs 95.45 Cr
14 November 2026

Orchid Pharma Q2 Results FY27: Net Profit Rs 28.59 Cr Against Loss, Revenue Rs 341.27 Cr
14 November 2026

TechNVision Ventures Q2 Results FY27: PAT Falls 38.03% to Rs 0.44 Cr, Revenue Rises to Rs 75.6 Cr
14 November 2026

Kalyani Cast-Tech Q2 Results FY27: PAT Rises 116.67% to Rs 0.52 Cr, Revenue Rs 132.01 Cr
14 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
AB Cotspin India Q2 Results FY27: PAT Jumps 56.35% to Rs 5.66 Cr, Revenue Rs 95.45 Cr
Orchid Pharma Q2 Results FY27: Net Profit Rs 28.59 Cr Against Loss, Revenue Rs 341.27 Cr
TechNVision Ventures Q2 Results FY27: PAT Falls 38.03% to Rs 0.44 Cr, Revenue Rises to Rs 75.6 Cr
Kalyani Cast-Tech Q2 Results FY27: PAT Rises 116.67% to Rs 0.52 Cr, Revenue Rs 132.01 Cr
Pavna Industries Q2 Results FY27: Net Loss Rs 1.19 Cr, Revenue Rises to Rs 110.09 Cr
Popular this week
Shalibhadra Finance Q2 Results FY27: PAT Rises 6.95% to Rs 5.08 Cr, Revenue Rs 11.33 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





